Skip to content
Nonprofiteer
← FOUNDATION FIGHTING BLINDNESS INC

Form 990 for tax year 2023

Filed by FOUNDATION FIGHTING BLINDNESS INC.

Totals

Total revenue
$35,702,558
Total expenses
$48,226,411
Contributions and grants received
$31,823,323
Grants paid
$21,112,113
Program service revenue
$1,028,762
Investment income
$1,323,599
Other revenue
$1,526,874
Total assets, end of year
$124,009,134
Total liabilities, end of year
$31,398,627
Net assets or fund balances, end of year
$92,610,507
Program services expenses (Part IX)
$37,406,725
Management and general expenses
$2,981,770
Fundraising expenses
$7,837,916
Program service expenses (Part III)
$37,406,725

Program services were 77.6% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1a · Federated campaigns

    $131,394

  • 1c · Fundraising events

    $6,084,961

  • 1f · All other contributions, gifts and grants

    $25,606,968

  • 1g · Noncash contributions included above

    $1,603,398

  • 2a · Program service revenue: CONTRACT REVENUE

    total $800,775 · related or exempt $800,775

  • 2b · Program service revenue: PROGRAM FEES

    total $227,987 · related or exempt $227,987

  • 3 · Investment income

    total $3,331,144 · excluded $3,331,144

  • 5 · Royalties

    total $1,673,311 · excluded $1,673,311

  • 6a · Gross rents

    real property $27,026

  • 6b · Less rental expenses

    real property $0

  • 6c · Rental income or loss

    real property $27,026

  • 6d · Net rental income or loss

    total $27,026 · excluded $27,026

  • 7a · Gross sales of assets other than inventory

    securities $62,884,148

  • 7b · Less cost or other basis and sales expenses

    securities $64,891,693

  • 7c · Gain or loss

    securities -$2,007,545

  • 7d · Net gain or loss

    total -$2,007,545 · excluded -$2,007,545

  • 8a · Fundraising events: gross income

    $891,321

  • 8a · Fundraising events: contributions included on line 1c

    $6,084,961

  • 8b · Fundraising events: direct expenses

    $1,064,784

  • 8c · Net income from fundraising events

    total -$173,463 · excluded -$173,463

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $17,518,008 · program services $17,518,008

  • 3 · Grants to foreign organizations and individuals

    total $3,594,105 · program services $3,594,105

  • 5 · Compensation of officers, directors and key employees

    total $1,815,946 · program services $851,708 · management and general $465,224 · fundraising $499,014

  • 7 · Other salaries and wages

    total $6,759,069 · program services $2,438,090 · management and general $878,708 · fundraising $3,442,271

  • 8 · Pension plan contributions

    total $370,386 · program services $138,198 · management and general $61,647 · fundraising $170,541

  • 9 · Other employee benefits

    total $978,136 · program services $374,911 · management and general $107,501 · fundraising $495,724

  • 10 · Payroll taxes

    total $591,522 · program services $220,734 · management and general $85,567 · fundraising $285,221

  • 11a · Fees: management

    total $1,899,001 · program services $1,388,825 · management and general $260,984 · fundraising $249,192

  • 11b · Fees: legal

    total $31,743 · program services $176 · management and general $31,567

  • 11c · Fees: accounting

    total $61,753 · management and general $57,345 · fundraising $4,408

  • 11d · Fees: lobbying

    total $240,000 · program services $240,000

  • 11e · Fees: professional fundraising services

    total $542,609 · fundraising $542,609

  • 11f · Fees: investment management

    total $211,519 · management and general $186,251 · fundraising $25,268

  • 12 · Advertising and promotion

    total $627,974 · program services $404,963 · management and general $6,854 · fundraising $216,157

  • 13 · Office expenses

    total $421,595 · program services $99,195 · management and general $95,163 · fundraising $227,237

  • 14 · Information technology

    total $451,089 · program services $29,236 · management and general $102,062 · fundraising $319,791

  • 16 · Occupancy

    total $125,741 · program services $17,761 · management and general $60,965 · fundraising $47,015

  • 17 · Travel

    total $572,038 · program services $205,437 · management and general $93,788 · fundraising $272,813

  • 19 · Conferences, conventions and meetings

    total $1,961,285 · program services $1,212,896 · management and general $290,574 · fundraising $457,815

  • 22 · Depreciation, depletion and amortization

    total $86,638 · program services $74,037 · management and general $254 · fundraising $12,347

  • 23 · Insurance

    total $204,648 · program services $115,856 · management and general $23,500 · fundraising $65,292

  • 24a · Other expenses: TRIAL RELATED COSTS

    total $8,261,887 · program services $8,261,887

  • 24b · Other expenses: PROF FUNDRAISING-OTHER

    total $330,133 · fundraising $330,133

  • 24c · Other expenses: PRINTING & PRODUCTION

    total $289,778 · program services $220,702 · management and general $14,887 · fundraising $54,189

  • 24e · All other expenses

    total $279,808 · management and general $158,929 · fundraising $120,879

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $4,523,190 · end of year $5,907,841

  • 2 · Savings and temporary cash investments

    beginning of year $3,113,386 · end of year $5,399,724

  • 3 · Pledges and grants receivable

    beginning of year $19,463,729 · end of year $16,206,701

  • 4 · Accounts receivable

    beginning of year $541,936 · end of year $553,927

  • 8 · Inventories for sale or use

    beginning of year $16,821 · end of year $16,732

  • 9 · Prepaid expenses and deferred charges

    beginning of year $774,207 · end of year $683,433

  • 10a · Land, buildings and equipment: cost or other basis

    $4,692,695

  • 10b · Land, buildings and equipment: accumulated depreciation

    $4,001,473

  • 10c · Land, buildings and equipment, net

    beginning of year $671,000 · end of year $691,222

  • 11 · Investments: publicly traded securities

    beginning of year $93,775,426 · end of year $85,735,053

  • 15 · Other assets

    beginning of year $8,011,660 · end of year $8,814,501

  • 17 · Accounts payable and accrued expenses

    beginning of year $1,993,845 · end of year $2,799,115

  • 18 · Grants payable

    beginning of year $20,414,511 · end of year $21,184,147

  • 19 · Deferred revenue

    beginning of year $442,676 · end of year $550,960

  • 25 · Other liabilities

    beginning of year $7,819,504 · end of year $6,864,405

  • 27 · Net assets without donor restrictions

    beginning of year $19,019,760 · end of year $20,614,062

  • 28 · Net assets with donor restrictions

    beginning of year $81,201,059 · end of year $71,996,445

Mission and programs · 2023

Mission

THE MISSION OF THE FOUNDATION FIGHTING BLINDNESS, INC. (FOUNDATION) IS TO DRIVE THE RESEARCH THAT WILL PROVIDE PREVENTIONS, TREATMENTS AND CURES, FOR PEOPLE AFFECTED BY RETINITIS PIGMENTOSA, MACULAR DEGENERATION, USHER SYNDROME, AND THE SPECTRUM OF RETINAL DEGENERATIVE DISEASES.

Activities or mission (Part I)

THE URGENT MISSION OF THE FOUNDATION FIGHTING BLINDNESS IS TO DRIVE THE RESEARCH THAT WILL PROVIDE PREVENTIONS, TREATMENTS AND CURES FOR PEOPLE AFFECTED BY RETINITIS PIGMENTOSA, AGE-RELATED MACULAR DEGENERATION, USHER SYNDROME AND THE ENTIRE SPECTRUM OF RETINAL DEGENERATIVE DISEASES. THE FOUNDATION IS A BEACON FOR THOSE AFFECTED BY THESE BLINDING DISEASES.

  • RESEARCH: THE FOUNDATION FIGHTING BLINDNESS, INC. (THE FOUNDATION) FUNDED RESEARCHERS ARE ACHIEVING REMARKABLE SUCCESS IN DISCOVERING, TESTING, AND DELIVERING TO PATIENTS A WIDE RANGE OF PROMISING THERAPIES TO PREVENT, STOP THE PROGRESSION OF, AND CURE BLINDNESS DUE TO RETINAL DEGENERATIVE DISEASES. THE FOUNDATION HAS ENCUMBRANCES OF OVER $43 MILLION, NOT INCLUDED ON OUR JUNE 30 FINANCIAL REPORT, FOR ACTIVE RESEARCH PROJECTS THAT HAVE FUTURE RESEARCH MILESTONES. OUR SCIENCE COMMITTEE'S SPENDING PLAN INCLUDES SPENDING AT AN AVERAGE OF $28 MILLION ANNUALLY TO SUPPORT FUTURE RESEARCH.AS OF THE END OF OUR FISCAL YEAR 2024, THE FOUNDATION'S RESEARCH GRANTS PROGRAM IS FUNDING 108 GRANTS BEING CONDUCTED BY MORE THAN 135 INVESTIGATORS AT 88 INSTITUTIONS, EYE HOSPITALS AND UNIVERSITIES IN THE U.S. AND AROUND THE WORLD. A SAMPLING OF THE RESEARCH PROJECTS FUNDED ARE LISTED BELOW."IN VIVO RETINAL RNA EDITING USING THE CELLULAR ADENOSINE DEAMINASE ACTING ON RNA (ADAR) ENZYME." - HADASSAH-HEBREW UNIVERSITY MEDICAL CENTERDOCTOR SHARON AND HIS TEAM WILL ADVANCE RNA EDITING TECHNOLOGY TO CORRECT SPECIFIC RETINAL DISEASE-CAUSING MUTATIONS. BY DEVELOPING AND ADMINISTERING NOVEL BIOLOGICAL MACHINERY TO THE RETINA THAT USES ENZYMES CALLED "ADENOSINE DEAMINASE ACTING ON RNA OR ADAR THAT SERVES AS MOLECULAR EDITORS TO CORRECT A SPECIFIC MUTATION IN RNA. THE TECHNIQUE IS LIKE GENE EDITING BUT INSTEAD OF EDITING THE GENE, THIS TECHNIQUE EDITS RNA, WHICH IS THE TRANSCRIPT OR MESSAGE READ FROM THE GENE TO PRODUCE PROTEIN."TESTING THE EFFICACY OF RT011, A DEUTERATED FORM OF DHA, AS A MUTATION INDEPENDENT THERAPY IN RETINITIS PIGMENTOSA." - KARSTEN SCHMIDT, BIOJIVABIOJIVA IS TESTING IF RT011, A NOVEL MUTATION-INDEPENDENT ORAL DRUG CANDIDATE, CAN PRESERVE RETINAL CONES AND CONE FUNCTION DESPITE ROD DEATH IN RETINITIS PIGMENTOSA. TO ACCOMPLISH THIS GOAL, THIS PROJECT WILL EVALUATE RT011 (D-DHA [DOCOSAHEXAENOIC ACID]), A DEUTERATED DHA ANALOGUE IN TWO COMPLEMENTARY ANIMAL MODELS OF CHRONIC RP (A JUVENILE PIG MODEL WITH EARLY RP ONSET AND AN ADULT MOUSE MODEL WITH LATE RP ONSET)."AAV- ANC80 GENE THERAPY PLATFORM TO TREAT VISION LOSS CAUSED BY RPGRIP1 MUTATIONS." - ASHLEY WINSLOW, ODYLIA THERAPEUTICS.DOCTOR WINSLOW IS LEADING THE TEAM AT ODYLIA THERAPEUTICS TO ADVANCE A GENE THERAPY FOR LEBER CONGENITAL AMAUROSIS (LCA6) RESULTING FROM RPGRIP1 MUTATIONS. THE THERAPY (OT-004) EMPLOYS THE ANC80 AAV CAPSID TO DELIVER A FUNCTIONAL RPGRIP1 GENE TO PHOTORECEPTORS. ODYLIA WILL CARRY OUT VECTOR PRODUCTION FOR TOXICOLOGY STUDIES, ASSESS VECTOR BIODISTRIBUTION AND TRANSGENE EXPRESSION, AND EVALUATE VECTOR SAFETY IN A 90-DAY TOXICOLOGY STUDY.

    Expenses $28,854,715 · Grants $21,112,113 · Revenue $1,028,762

  • PUBLIC HEALTH EDUCATION:DURING FISCAL YEAR 2024, THROUGH OUR CHATLOS FOUNDATION PUBLIC EDUCATION PROGRAM, THE FOUNDATION AIMED TO CONTINUE TO PROVIDE EDUCATION AND SUPPORT TO PEOPLE AFFECTED BY RETINAL DEGENERATIVE DISEASES. THE FOUNDATION ALSO FIELDS A TEAM OF PROFESSIONALS FOCUSED ON EDUCATING OPHTHALMOLOGISTS AND OPTOMETRISTS ON THE LATEST ADVANCEMENTS WITH THE FOUNDATION'S RESOURCES AND RESEARCH ON THE INHERITED RETINAL DISEASE SPACE. TO KEEP OUR CONSTITUENTS AND PROFESSIONALS INFORMED, THE FOUNDATION PUBLISHES EXTENSIVE CONTENT VIA THE WEBSITE AND SOCIAL MEDIA/EMAIL CHANNELS; DISTRIBUTES A NEWSLETTER ONLINE AND IN PRINT; PRODUCES AND SHARES EDUCATIONAL PODCASTS WITH LEADING EXPERTS IN THE SPACE; AND HOLDS QUARTERLY INSIGHTS FORUM CALLS TO INFORM THE COMMUNITY ABOUT SCIENTIFIC PROGRESS. THE CONTENT PRODUCED INCLUDES THE LATEST DEVELOPMENTS IN RESEARCH AND CLINICAL TRIALS, AS WELL AS PERSONAL STORIES FROM MEMBERS OF THE FIGHTING BLINDNESS COMMUNITY. ADDITIONALLY, THE FOUNDATION HOLDS CONTINUING MEDICAL EDUCATION COURSES TWICE A YEAR, FOCUSED ON PROVIDING TIMELY CONTENT TO EYE CARE PROFESSIONALS. CHAPTERS BRING THE FOUNDATION'S MESSAGE AND MISSION TO LIFE. IN FY24, THE FOUNDATION SUPPORTED OVER 47 VOLUNTEER-LED CHAPTERS IN 23 STATES AND EXPANDED OUT OF THE US BY ADDING TWO NEW CHAPTERS IN LONDON, UK, AND PARIS, FRANCE. OUR CHAPTERS LAUNCHED A NEW PROGRAM, VISION CONNECTION, AN ENRICHING AND SUPPORTIVE GATHERING FOR THE BLIND AND LOW-VISION COMMUNITY. EACH SESSION COVERS EDUCATIONAL PRESENTATIONS, COMMUNITY ENGAGEMENT, FUNDRAISING, AND INTERACTIVE Q&A SESSIONS.

    Expenses $4,249,284

  • MY RETINA TRACKER REGISTRY:THE FOUNDATION MAINTAINS A RESEARCH DATABASE OF PEOPLE AND FAMILIES AFFECTED BY RARE INHERITED RETINAL DEGENERATIVE DISEASES. THE REGISTRY IS DESIGNED TO SHARE DE-IDENTIFIED INFORMATION ABOUT PEOPLE WITH AN INHERITED RETINAL DISEASE WITHIN THE IRD RESEARCH AND CLINICAL COMMUNITIES TO HELP ACCELERATE THE DISCOVERY OF TREATMENTS AND CURES. DURING FISCAL YEAR 2024, APPROXIMATELY 10,000 ADDITIONAL MEMBERS WERE ADDED TO THE REGISTRY, BRINGING THE TOTAL NUMBER OF REGISTERED INDIVIDUALS TO OVER 35,000.

    Expenses $4,302,726

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • David Brint

    CHAIRMAN OF THE BOARD

    Total calculated
    $0
    Hours/week
    10 + 1 related
  • Jonathan Steinberg MD

    VICE CHAIR, RESEARCH

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Karen Petrou

    EXECUTIVE VICE CHAIR

    Total calculated
    $0
    Hours/week
    1
  • Maryrose Sylvester

    VICE CHAIR, AT LARGE

    Total calculated
    $0
    Hours/week
    1
  • Steven Alper

    INTERIM VICE CHAIR, DEVELOPMENT

    Total calculated
    $0
    Hours/week
    1
  • Jason Morris

    VICE CHAIR, BOARD COMM & DEV/TREASURER

    Total calculated
    $0
    Hours/week
    1
  • Bradford Manning

    VICE CHAIR, MARKETING, COMM & SOCIAL MEDIA

    Total calculated
    $0
    Hours/week
    1
  • Haynes Lea

    SECRETARY

    Total calculated
    $0
    Hours/week
    1
  • Gordon Gund

    DIRECTOR - CHAIRMAN EMERITUS

    Total calculated
    $0
    Hours/week
    1
  • Scott Burt

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • William Carty

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Darren Devoue

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Jason Ferreira

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Jeffrey Freed

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Adrienne Graves Ph D

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Robert Heidenberg

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Janice Lehrer-Stein

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Marsha Link PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Laura Manfre

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Evan Mittman

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • David Nixon

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Warren Thaler

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Janine Marks Nixon

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Martha Steele

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Joshua Steinberg

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Jason D Menzo

    CEO

    Total calculated
    $588,996
    From this org
    $416,489
    From related orgs
    $104,122
    Other
    $68,385
    Hours/week
    32 + 8 related

    Schedule J breakdown matched by us

    Base
    $336,556 + $84,139 related
    Bonus
    $79,645 + $19,911 related
    Other
    $288 + $72 related
    Deferred
    $14,656 + $3,664 related
    Nontaxable benefits
    $40,052 + $10,013 related
    Filer's total
    $471,197 + $117,799 related
  • Peter Ginsberg

    COO

    Total calculated
    $425,796
    From this org
    $290,019
    From related orgs
    $72,505
    Other
    $63,272
    Hours/week
    32 + 8 related

    Schedule J breakdown matched by us

    Base
    $253,239 + $63,310 related
    Bonus
    $35,954 + $8,989 related
    Other
    $826 + $206 related
    Deferred
    $14,901 + $3,725 related
    Nontaxable benefits
    $35,717 + $8,929 related
    Filer's total
    $340,637 + $85,159 related
  • Claire Gelfman

    CHIEF SCIENTIFIC OFFICER

    Total calculated
    $453,161
    From this org
    $392,360
    From related orgs
    $0
    Other
    $60,801
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $342,166
    Bonus
    $48,610
    Other
    $1,584
    Deferred
    $12,043
    Nontaxable benefits
    $48,758
    Filer's total
    $453,161
  • Richele Donat

    CHRO

    Total calculated
    $299,448
    From this org
    $265,633
    From related orgs
    $0
    Other
    $33,815
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $232,420
    Bonus
    $32,266
    Other
    $947
    Deferred
    $15,992
    Nontaxable benefits
    $17,823
    Filer's total
    $299,448
  • Judy L Taylor

    SVP, CHIEF DEVELOPMENT OFFICER

    Total calculated
    $287,017
    From this org
    $227,974
    From related orgs
    $0
    Other
    $59,043
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $197,745
    Bonus
    $28,994
    Other
    $1,235
    Deferred
    $13,538
    Nontaxable benefits
    $45,505
    Filer's total
    $287,017
  • Russell W Kelley

    MANAGING DIRECTOR, RD FUND

    Total calculated
    $412,493
    From this org
    $0
    From related orgs
    $347,534
    Other
    $64,959
    Hours/week
    0 + 40 related

    Schedule J breakdown matched by us

    Base
    $0 + $296,734 related
    Bonus
    $0 + $50,248 related
    Other
    $0 + $552 related
    Deferred
    $0 + $18,571 related
    Nontaxable benefits
    $0 + $46,388 related
    Filer's total
    $0 + $412,493 related
  • Todd A Durham

    VP, CLINICAL & OUTCOMES RESEARCH

    Total calculated
    $323,263
    From this org
    $262,294
    From related orgs
    $0
    Other
    $60,969
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $238,960
    Bonus
    $22,795
    Other
    $539
    Deferred
    $14,099
    Nontaxable benefits
    $46,870
    Filer's total
    $323,263
  • Christopher S Adams

    VP, COMMUNICATIONS & MARKETING

    Total calculated
    $243,031
    From this org
    $192,708
    From related orgs
    $0
    Other
    $50,323
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $174,359
    Bonus
    $17,975
    Other
    $374
    Deferred
    $2,027
    Nontaxable benefits
    $48,296
    Filer's total
    $243,031
  • Michele C Divincenzo

    VP, SCIENTIFIC & EDUCATIONAL CONFERENCES

    Total calculated
    $248,184
    From this org
    $199,289
    From related orgs
    $0
    Other
    $48,895
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $177,695
    Bonus
    $20,900
    Other
    $694
    Deferred
    $12,098
    Nontaxable benefits
    $36,797
    Filer's total
    $248,184
  • Amy M Palmer Laster

    SVP, SCIENCE STRATEGY & AWARDS

    Total calculated
    $237,524
    From this org
    $220,621
    From related orgs
    $0
    Other
    $16,903
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $201,581
    Bonus
    $18,618
    Other
    $422
    Deferred
    $11,697
    Nontaxable benefits
    $5,206
    Filer's total
    $237,524
  • Jeffry C Collins

    VP, DATABASE SYSTEMS & TECHNOLOGY

    Total calculated
    $233,680
    From this org
    $192,978
    From related orgs
    $0
    Other
    $40,702
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $172,455
    Bonus
    $19,507
    Other
    $1,016
    Deferred
    $11,687
    Nontaxable benefits
    $29,015
    Filer's total
    $233,680
  • Chad R Jackson

    SR DIR, PRE-CLINICAL TRANSLATIONAL PROG

    Total calculated
    $213,824
    From this org
    $197,593
    From related orgs
    $0
    Other
    $16,231
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $176,521
    Bonus
    $20,920
    Other
    $152
    Deferred
    $11,560
    Nontaxable benefits
    $4,671
    Filer's total
    $213,824

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 1a · Tax indemnification and gross-up payments
  • 1b · Written policy on the line-1a expenses
  • 2 · Substantiation required before reimbursing expenses
  • 3 · Compensation committee
  • 3 · Independent compensation consultant
  • 3 · Form 990 of other organizations
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 7 · Other non-fixed payments

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, LINE 1A
SPOT BONUSES FOR EXTRAORDINARY WORK ARE PROVIDED TO EMPLOYEES. IF THE BONUS IS $1,000 OR LESS, IT IS GROSSED UP. THESE SPOT BONUSES AND GROSS UPS ARE INCLUDED IN TAXABLE COMPENSATION.
PART I, LINE 7
FFB EMPLOYEES PARTICIPATE IN AN ANNUAL INCENTIVE PLAN. THE PLAN PROVIDES AN ANNUAL CASH BONUS DEPENDING UPON THE ACHIEVEMENT OF PRE-DETERMINED ORGANIZATION AND INDIVIDUAL PERFORMANCE CRITERIA.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Fundraising and gaming

From Schedule G of this return, as filed.

Raised funds through (line 1)
mail, email, phone, in person, non-government grants, special fundraising events
Had an agreement with a professional fundraiser (line 2a)
Yes
Registered or licensed to solicit in (line 3)
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY

Professional fundraisers (line 2b)

Their names and addresses are not shown.

Activity Custody of contributions Gross receipts Kept by fundraiser To the organization
FUNDRAISING COUNSEL No $1,114,074 $674,993 $439,081
FUNDRAISING COUNSEL No $0 $77,439 -$77,439
FUNDRAISING COUNSEL No $0 $120,310 -$120,310
Total, as filed $1,114,074 $872,742 $241,332

Fundraising events (Part II)

Part II has at most four columns: the two largest events, the rest together, and the total.

Line Event 1 NIGHT FOR SIGHT Event 2 VISIONWALK - NEW YORK Other events 53 events Total
Gross receipts (line 1) $680,638 $415,770 $5,879,874 $6,976,282
Less contributions (line 2) $518,938 $415,770 $5,150,253 $6,084,961
Gross income (line 3) $161,700 — $729,621 $891,321
Cash prizes (line 4) — — — —
Noncash prizes (line 5) — — — —
Rent and facility costs (line 6) $145,553 — $416,706 $562,259
Food and beverages (line 7) — — $106,099 $106,099
Entertainment (line 8) $8,900 — $26,417 $35,317
Other direct expenses (line 9) $35,814 — $325,295 $361,109
Direct expenses (line 10)
$1,064,784
Net income (line 11)
-$173,463

Activities outside the United States

From Schedule F of this return, as filed.

Offices (line 3c)
0
Employees, agents and contractors (line 3c)
0
Expenditures and investments (line 3c)
$3,651,305

At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.

Activities by region (Part I)

Region Offices Employees Activity Specific services Expenditures
EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTMAKING — $3,391,431
NORTH AMERICA 0 0 GRANTMAKING — $202,674
EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES TRAVEL $57,200

Grants to organizations, by region (Part II)

The purpose of each grant is not shown.

Region Cash grants Manner of disbursement Noncash assistance Noncash description Valuation
EUROPE (INCLUDING ICELAND & GREENLAND) $290,505 WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $294,518 WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $469,000 WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $872,356 WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $100,000 WIRE $0 — —
NORTH AMERICA $127,674 WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $617,500 WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $99,204 WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $548,348 WIRE $0 — —
NORTH AMERICA $75,000 WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $100,000 WIRE $0 — —
Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
10
Other grantees (Part II line 3)
1
Transferred property to a foreign corporation during the year (line 1)
No
Had an interest in a foreign trust (line 2)
No
Owned an interest in a foreign corporation (line 3)
No
Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
No
Owned an interest in a foreign partnership (line 5)
No
Had operations in or related to a boycotting country (line 6)
No

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Provenance

Return type
form_990
Tax year
2023
Filed
5 November 2024
IRS schema version
2023v5.1
Source object
202433129349301503

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.